Replies to post #4847 on Halozyme Therapeutics Inc (HALO)

[jamtomorrow2]

There a lot of posts about potential revenues - most (other than Mab SQ) kicking in from 2020 onwards. In the meantime we are where we are. This is going to be a record loss quarter for sure. How high - well depending on the huge PEG expenditure it could be between $35m - $40m.

[maumar]

I don't remember the exact number. I am very curious to know how you are adjusting your forecast if the approval does happen in June '17.